Latest News about ARGX
Recent news which mentions ARGX
Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development
July 18, 2023
From Benzinga
From Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 17, 2023
From Benzinga
From Motley Fool
From Benzinga
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket
July 17, 2023
From Benzinga
From InvestorPlace
Why Are Argenx Shares Trading Higher Today?
July 17, 2023
From Benzinga
From InvestorPlace
Why Is Argenx (ARGX) Stock Up 27% Today?
July 17, 2023
From InvestorPlace
From InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
From Benzinga
From Motley Fool
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
June 27, 2023
From Benzinga
From Benzinga
Argenx's Vyvgart Hytrulo Becomes First FDA Approved Subcutaneous Option For Generalized Myasthenia Gravis
June 21, 2023
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.